The incidence of transient reductions in serum free T 4 (FT 4 ) in premature infants may be overestimated because certain FT 4 analytical methods underestimate FT 4 concentrations. Transient reductions of FT 4 measurements have been reported in the majority of premature newborn infants. Direct equilibrium dialysis (DED) does not underestimate FT 4 concentrations and is the best available technique to measure serum FT 4 in the premature infant.
INTRODUCTION
Thyroid hormones play a critical role in fetal and neonatal development and are directly involved in pulmonary, neurologic, and musculoskeletal growth and development. In the absence of adequate thyroid hormone profound growth, neurologic, and respiratory impairment may result. [1] [2] [3] [4] [5] Therefore, accurate assessment of thyroid function and in particular, free thyroxine (FT 4 ) levels in premature infants is essential for diagnosis and management.
Thyroid function in healthy term neonates is characterized by an immediate postnatal increase in circulating thyroid-stimulating hormone (TSH) concentrations followed by increases in total thyroxine (T 4 ), FT 4 , and total and free triiodothyronine concentrations. In infants born prematurely, circulating levels of TSH and T 4 are lower than in full-term infants during the first 2 weeks of life. 1, [6] [7] [8] [9] [10] Transient reduction in FT 4 values without a corresponding increase in TSH measurements is a condition that has been reported to occur in the majority of premature infants. 1, [10] [11] [12] [13] [14] [15] [16] Historically, a nadir in FT 4 levels has been observed at day 7-14 of life. 1, 5, [10] [11] [12] [13] [14] [15] [16] The nadir is associated with normal or low TSH values and normal TSH and T 4 responses to thyrotropin releasing hormone, indicating a normally responsive hypothalamicpituitary-thyroid regulating system. 17 Transient reduction in FT 4 measurements may be related to immaturity of the hypothalamicpituitary-thyroid axis and/or reduced T 4 binding to serum proteins resulting in underestimates of FT 4 concentrations obtained with FT 4 index or analog FT 4 immunoassay methods. 4,6,8,11,12,16,18 -24 The observed reduction in FT 4 values is temporary and spontaneous correction occurs with progressive maturation by 4 to 8 weeks of postnatal life. 17 The earlier studies demonstrating low FT 4 4 values may have been misclassified as a result of laboratory methodology that is biased by low serum proteins and/or reduced T 4 protein binding. The purpose of this study was to determine the incidence of low FT 4 values using DED to measure FT 4 .
METHODS

Subjects
All premature infants <1500 g born at or transported to the NICU at Loma Linda University Children's Hospital were candidates for the study. Infants were excluded from the study if they had complex congenital anomalies, or maternal history of thyroid disorder.
Infants were stratified by gestational age at birth into three groups: r27, 28 to 30, and 31 to 33 weeks of gestation. Gestational age was assigned based on early obstetric ultrasound studies and maternal dates whenever those data were available. Otherwise, gestational age was assessed by the Ballard Maturational Score performed within 24 h of delivery. When there was a discrepancy greater than 2 weeks between those methods, the Ballard physical assessment gestational age was used.
This study was reviewed and approved by our Institutional Review Board. Informed consent was obtained from the parents or guardians of the infants. Blood samples were obtained from infants at 14 days of age. If an umbilical arterial or venous catheter was already in place for clinical reasons, the blood sample was drawn from the catheter. Otherwise samples were obtained by venipuncture when blood samples were drawn for routine laboratory work. Free T 4 values measured by DED are not known to be altered by the method used in obtaining the blood sample. All assays were performed at Loma Linda University Children's Hospital Clinical Laboratory using a Model LB 2103 Berthold processor and a kit provided by Nichols Institute Diagnostics, San Juan Capistrano, California for the analysis of FT 4 by DED.
Clinical information also collected were nutritional laboratory testing including triglyceride levels, presence of sepsis defined as a positive blood culture, respiratory distress syndrome (RDS) defined by intubation and surfactant administration in the first week of life, and intraventricular hemorrhage (IVH). 26 Infants in the study had a TSH level measured only if they had a low FT 4 value. The TSH level was drawn after the return of the low FT 4 measurement.
Assay methods
Free T 4 was measured by DED with an interassay coefficient of variation of 8.5% at 20 pmol/l (1.56 ng/dl). This method uses a semipermeable dialysis membrane to withhold serum proteins and protein-bound T 4 from the dialysate in which FT 4 is measured. Free T 4 is then measured directly using a radioimmunoassay calibrated to gravimetrically determined assay standards in which 100% of T 4 is FT 4 . 27 The incidence of low FT 4 values was calculated using a statistically defined reference range from data reported for this method in premature infants beyond the first week of life (10.3 pmol/l (0.8 ng/dl)). 28 
Data analysis
We calculated the incidence of low FT 4 values with 95% confidence interval for premature infants by gestational age as well as for the entire patient population. Free T 4 values were compared for patients with and without RDS, sepsis, and grade 3 to 4 IVH for each gestational age group. Comparisons between groups were done utilizing t-tests, w 2 analysis, and the Mann-Whitney U. Because our primary intent was to calculate the incidence of low FT 4 values we did not do a power analysis for the comparisons between groups.
RESULTS
During the study period from May 2000 to June 2001, 116 infants less than 1500 g were admitted to the NICU at Loma Linda University Children's Hospital. Two infants were excluded from the study with congenital anomalies. Of the 114 remaining infants, there were 56 boys and 58 girls. Samples were obtained from these infants at 14.5±1.8 days of age (mean and standard deviation, Table 1 ). There were no differences in the incidence of RDS or sepsis between the infants with and without low FT 4 values ( Figure 1 ). As would be expected, more infants in the r27-week gestational age group had RDS. When using 10.3 pmol/l (0.8 ng/dl) as the lower limit, low FT 4 levels were seen in nine of 114 infants representing an incidence of 7.9%. The nine infants with low FT 4 all had normal TSH levels, demonstrating absence of primary hypothyroidism. Free T 4 was lower in younger gestational age and lower birth weight infants ( Table 1 ). The incidence of low FT 4 was inversely related to gestational age (Table 2) .
Free T 4 values were lower for infants with RDS in the r27-week gestational age group. Free T 4 values were higher for infants with grade 3-4 IVH in the 28 to 30 week gestational age group. There were no other differences in FT 4 values between any of the other groups (Figure 1 ).
DISCUSSION
Low FT 4 values have previously been reported in the majority of premature infants. 1, 4, [10] [11] [12] [13] [14] [15] [16] In these studies, FT 4 was measured by methodologies (FT 4 analog immunoassays and FT 4 index methods) that are variably affected by reduced serum protein concentrations and reduced serum protein T 4 binding. In vitro studies have demonstrated that with reduced protein T 4 binding, concentrations of FT 4 can be significantly underestimated using nondialysis assays. [18] [19] [20] [21] [22] In this study, we calculated the incidence of low FT 4 values using the published method-specific reference range data for premature infants beyond the first week of life by 4 by direct equilibrium dialysis <10.3 pmol/l (0.8 ng/dl) Clark, et al. 28 Percentages within the gestational age groups are percent of the total number of patients for that gestational age group. Percentages in the Total column are percent of the total number of patients in the study. Rabin et al.
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DED (Table 1) . 28 This method has been reported to differentiate low FT 4 values due to hypothyroidism from low total T 4 states caused by reduced protein T 4 binding. 25 Using the DED assay in 114 consecutive preterm infants at 2 weeks postnatal age; the incidence of low FT 4 values was 7.9%. The incidence of low FT 4 values in our patient population increased with decreasing gestational age and birth weight ( Table 2 ). Also of interest was a statistically higher mean FT 4 value in grade 3 to 4 IVH infants in the 28 to 30 week gestational age group, which may be due to the small sample size (n ¼ 5).
Measurements obtained by DED are constant across the range of variability in protein bound T 4 to FT 4 (911 to 12,300 ng of protein bound T 4 per nanogram of free T 4 ). [20] [21] [22] 27 Some widely used clinical laboratory FT 4 methods underestimate actual FT 4 concentrations in the solutions they analyze. These underestimates increase as the protein bound T 4 to FT 4 ratios decrease. [18] [19] [20] [21] [22] Consequently, inconsistencies among clinical laboratory methods used to obtain FT 4 measurements may account for the observed differences in the reported incidence of low FT 4 values. Until these inconsistencies have been resolved, the issue of which premature infants have thyroid hormone insufficiency versus reduced serum T 4 binding will remain confusing.
The blood volume and cost for the dialysis and nondialysis assays are very comparable. The minimum volume of serum required to process an FT 4 by DED is 0.2 ml compared to 0.5 ml minimum serum volume using a nondialysis assay. The current list price of the FT 4 DED is $94.00 compared to the $82.00 for the nondialysis assay (personal communication, Quest Diagnostics).
Direct equilibrium dialysis assay can have altered values secondary to heparin that can cause an artifactual elevation in the concentration of FT 4 in the plasma. [29] [30] [31] [32] This artifact occurs only in the presence of elevated serum triglycerides (greater than approximately 180 mg/dl). 29, 31 In this study, we retrospectively reviewed our study population triglyceride levels that were drawn within several days of their respective FT 4 measurements and found that only three infants had levels over 180 ng/dl. This evaluation of FT 4 values and triglyceride levels was not optimal but did not seem to be a major contributor to our findings.
Previous studies with thyroxine supplementation have shown little benefit in preterm infants with transient low FT 4 values. [33] [34] [35] In order to demonstrate benefit from thyroxine supplementation, it is necessary to identify correctly infants with ''true'' transient low FT 4 values, not transient low FT 4 values based on biased measurements. If only ''true'' thyroid hormone insufficient infants are enrolled in clinical studies, it might be then possible to demonstrate clinical improvement in pulmonary, neurologic and musculoskeletal growth and development with thyroxine supplementation.
It is essential to use an accurate and precise method to measure FT 4 values. While DED is an improved method, it too is still susceptible to previously described error such as that seen with elevated triglycerides and heparin use. However, DED is a more reproducible test and one less vulnerable to high variations in serum binding proteins in preterm infants.
We conclude that using direct equilibrium dialysis method of measuring FT 4 the incidence of transient low FT 4 values is much lower than previously reported.
